
<p>{{Taxobox}}
<b><i>Helicobacter pylori</i></b> ({{pronEng}}) is a <a href="/wiki/Gram-negative" id="w">Gram-negative</a>, <a href="/wiki/Microaerophile" id="w">microaerophilic</a>, and <a href="/wiki/Acidophile" id="w">acidophilic</a> <a href="/wiki/Bacterium" id="w">bacterium</a> that <a href="/wiki/Infection" id="w">infects</a> various areas of the <a href="/wiki/Stomach" id="w">stomach</a> and <a href="/wiki/Duodenum" id="w">duodenum</a>. Many cases of <a href="/wiki/Peptic_ulcer" id="w">peptic ulcers</a>, <a href="/wiki/Gastritis" id="w">gastritis</a>, <a href="/wiki/Duodenitis" id="w">duodenitis</a>, and perhaps some <a href="/wiki/Cancer_bacteria" id="w">cancers</a> are caused by <i>H. pylori</i> infections.  However, many who are infected do not show any symptoms of <a href="/wiki/Disease" id="w">disease</a>.  <i>Helicobacter</i> spp. are the only known microorganisms that can thrive in the highly <a href="/wiki/Acid" id="w">acidic</a> environment of the stomach.  <i>H. pylori<b>s helical shape (from which the <a href="/wiki/Genus" id="w">genus</a> name is derived) is thought to have evolved to penetrate and favor its <a href="/wiki/Motility" id="w">motility</a> in the <a href="/wiki/Mucus" id="w">mucus</a> gel layer.<sup id="_ref-1" class="reference"><a href="#_note-1" title="">[1]</a></sup></b></i></p>
<a id="History" name="History"></a><h2>History</h2>
<p>{{see also}}</p>
<p>In 1875, <a href="/wiki/Germany" id="w">German</a> scientists found <a href="/wiki/Helical" id="w">helical</a> shaped <a href="/wiki/Bacteria" id="w">bacteria</a> in the lining of the human <a href="/wiki/Stomach" id="w">stomach</a>.  The bacteria could not be grown in <a href="/wiki/Culture" id="w">culture</a> and the results were eventually forgotten.<sup id="_ref-Blaser_2005_a" class="reference"><a href="#_note-Blaser_2005" title="">[2]</a></sup> </p>
<p>In 1893, the <a href="/wiki/Italy" id="w">Italian</a> researcher <a href="/wiki/Giulio_Bizzozero" id="w">Giulio Bizzozero</a> described helical shaped bacteria living in the acidic environment of the stomach of <a href="/wiki/Dog" id="w">dogs</a>.<sup id="_ref-3" class="reference"><a href="#_note-3" title="">[3]</a></sup></p>
<p>Professor <a href="/wiki/Walery_Jaworski" id="w">Walery Jaworski</a> of the <a href="/wiki/Jagiellonian_University" id="w">Jagiellonian University</a> in <a href="/wiki/Krak%C3%B3w" id="w">Kraków</a> investigated sediments of <a href="/wiki/Gastric" id="w">gastric</a> washings obtained from humans in 1899. Among some rod-like bacteria, he also found bacteria with a characteristic helical shape, which he called <i>Vibrio rugula</i>. He was the first to suggest a possible role of this organism in the pathogeny of gastric diseases. This work was included in the &#34;Handbook of Gastric Diseases&#34; but it did not have much impact as it was written in <a href="/wiki/Polish_language" id="w">Polish</a>.<sup id="_ref-4" class="reference"><a href="#_note-4" title="">[4]</a></sup></p>
<p>The bacterium was rediscovered in 1979 by <a href="/wiki/Australia" id="w">Australian</a> pathologist <a href="/wiki/Robin_Warren" id="w">Robin Warren</a>, who did further research on it with <a href="/wiki/Barry_Marshall" id="w">Barry Marshall</a> beginning in 1981; they isolated the organisms from mucosal specimens from human stomachs and were the first to successfully culture them.<sup id="_ref-5" class="reference"><a href="#_note-5" title="">[5]</a></sup> In their original paper,<sup id="_ref-6" class="reference"><a href="#_note-6" title="">[6]</a></sup> Warren and Marshall contended that most stomach ulcers and gastritis were caused by infection by this bacterium and not by <a href="/wiki/Stress_(medicine)" id="w">stress</a> or <a href="/wiki/Spicy_food" id="w">spicy food</a> as had been assumed before.<sup id="_ref-7" class="reference"><a href="#_note-7" title="">[7]</a></sup></p>
<p>The medical community was slow to recognize the role of this <a href="/wiki/Bacterium" id="w">bacterium</a> in <a href="/wiki/Stomach_ulcer" id="w">stomach ulcers</a> and <a href="/wiki/Gastritis" id="w">gastritis</a>, believing that no <a href="/wiki/Microorganism" id="w">microorganism</a> could survive for long in the acidic environment of the stomach.  The community began to come around after further studies were done, including one in which Marshall drank a Petri dish of <i>H. pylori</i>, developed gastritis, and the bacteria were recovered from his stomach lining, thereby satisfying three out of the four <a href="/wiki/Koch%26%2339%3Bs_postulates" id="w">Koch&#39;s postulates</a>. The fourth was satisfied after a second endoscopy ten days after inoculation revealed signs of gastritis and the presence of &#34;H. pylori&#34;.  Marshall was then able to treat himself using a fourteen day dual therapy with <a href="/wiki/Bismuth" id="w">bismuth</a> salts and <a href="/wiki/Metronidazole" id="w">metronidazole</a>. Marshall and Warren went on to show that antibiotics are effective in the treatment of many cases of gastritis. In 1994, the <a href="/wiki/National_Institutes_of_Health" id="w">National Institutes of Health</a> (USA) published an opinion stating that most recurrent gastric ulcers were caused by <i>H. pylori</i>, and recommended that <a href="/wiki/Antibiotics" id="w">antibiotics</a> be included in the treatment regimen.<sup id="_ref-8" class="reference"><a href="#_note-8" title="">[8]</a></sup>   Evidence has been accumulating to suggest that <a href="/wiki/Duodenal_ulcer" id="w">duodenal ulcers</a> are also associated with <i>H. pylori</i> infection.<sup id="_ref-9" class="reference"><a href="#_note-9" title="">[9]</a></sup><sup id="_ref-10" class="reference"><a href="#_note-10" title="">[10]</a></sup> In 2005, Warren and Marshall were awarded the <a href="/wiki/Nobel_Prize_in_Medicine" id="w">Nobel Prize in Medicine</a> for their work on <i>H. pylori</i>.<sup id="_ref-11" class="reference"><a href="#_note-11" title="">[11]</a></sup></p>
<p>Before the appreciation of the bacterium&#39;s role, stomach ulcers were typically treated with <a href="/wiki/Medicine" id="w">medicines</a> that neutralize <a href="/wiki/Gastric_acid" id="w">gastric acid</a> or decrease its production. While this worked well, the ulcers very often reappeared. A very often used medication against gastritis and peptic ulcers was <a href="/wiki/Bismuth_subsalicylate" id="w">bismuth subsalicylate</a>. It was often effective, but fell out of use, since its mechanism of action was a mystery.  Nowadays it is quite clear that it is due to the bismuth salt acting as an antibiotic. Today, many stomach ulcers are treated with antibiotics effective against <i>H. pylori</i>.</p>
<p>The bacterium was initially named <b><i>Campylobacter pyloridis</i></b>, then <b><i>C. pylori</i></b> (after a correction to the <a href="/wiki/Latin_grammar" id="w">Latin grammar</a>) and in 1989, after <a href="/wiki/DNA_sequencing" id="w">DNA sequencing</a> and other data showed that the bacterium did not belong in the <i><a href="/wiki/Campylobacter" id="w">Campylobacter</a></i> genus, it was placed in its own <a href="/wiki/Genus" id="w">genus</a>, <i><a href="/wiki/Helicobacter" id="w">Helicobacter</a></i>.  The name <i>pylōri</i> means &#34;of the pylorus&#34; or <a href="/wiki/Pyloric_valve" id="w">pyloric valve</a> (the circular opening leading from the stomach into the <a href="/wiki/Duodenum" id="w">duodenum</a>), from the <a href="/wiki/Greek_language" id="w">Greek</a> word <i>πυλωρός</i>, which means <a href="/wiki/Gatekeeper" id="w">gatekeeper</a>.</p>
<p>While <i>H. pylori</i> remains the most <a href="/wiki/Medical" id="w">medically</a> important <a href="/wiki/Bacterial" id="w">bacterial</a> inhabitant of the human stomach, other species of the <i>Helicobacter</i> genus have been identified in other <a href="/wiki/Mammal" id="w">mammals</a> and some <a href="/wiki/Bird" id="w">birds</a>, and some of these can infect humans.<sup id="_ref-12" class="reference"><a href="#_note-12" title="">[12]</a></sup> <i>Helicobacter</i> species have also been found to infect the <a href="/wiki/Liver" id="w">livers</a> of certain mammals and to cause liver disease.<sup id="_ref-Starzyñska_2006_a" class="reference"><a href="#_note-Starzyñska_2006" title="">[13]</a></sup></p>
<a id="Structure" name="Structure"></a><h2>Structure</h2>
<p><i>H. pylori</i> is a helical shaped <a href="/wiki/Gram-negative" id="w">Gram-negative</a> bacterium, about <a href="/wiki/1_E-6_m" id="w">3 micrometres</a> long with a diameter of about 0.5 micrometre. It has 4&#8211;6 <a href="/wiki/Flagellum" id="w">flagella</a>. It is <a href="/wiki/Microaerophilic" id="w">microaerophilic</a>, i.e. it requires <a href="/wiki/Oxygen" id="w">oxygen</a> but at lower levels than those contained in the <a href="/wiki/Earth%26%2339%3Bs_atmosphere" id="w">atmosphere</a>. It contains a <a href="/wiki/Hydrogenase" id="w">hydrogenase</a> which can be used to obtain energy by oxidizing molecular <a href="/wiki/Hydrogen" id="w">hydrogen</a> (H<sub>2</sub>) that is produced by other intestinal bacteria.<sup id="_ref-14" class="reference"><a href="#_note-14" title="">[14]</a></sup> It tests positive for <a href="/wiki/Oxidase_test" id="w">oxidase</a>, <a href="/wiki/Catalase" id="w">catalase</a>, and <a href="/wiki/Urease" id="w">urease</a>. It is capable of forming <a href="/wiki/Biofilm" id="w">biofilms</a><sup id="_ref-15" class="reference"><a href="#_note-15" title="">[15]</a></sup> and conversion from helical to <a href="/wiki/Coccus" id="w">coccoid</a> form<sup id="_ref-16" class="reference"><a href="#_note-16" title="">[16]</a></sup>, both likely to favor its survival and be factors in the <a href="/wiki/Epidemiology" id="w">epidemiology</a> of the bacterium.  The coccoid form of the organism has not been cultured, but has been found in the water supply in the US. This form has also been found to be able to adhere to gastric epithelial cells <i><a href="/wiki/In_vitro" id="w">in vitro</a></i>.</p>
<p><div style="wigth:250px"><a class="internal" href="/wiki/Image:250px-Helicobacter_Pylori_Urease.png" title="Molecular model of &#39;&#39;H. pylori&#39;&#39; urease enzyme"><img src="http://en.wikipedia.org/wiki/250px-Helicobacter_Pylori_Urease.png" alt="Molecular model of &#39;&#39;H. pylori&#39;&#39; urease enzyme" title="Molecular model of &#39;&#39;H. pylori&#39;&#39; urease enzyme" class="location-none type-thumb" width="250px" />
</a>
<div class="thumbcaption">Molecular model of <i>H. pylori</i> urease enzyme</div></div>
</p>
<a id="Colonization" name="Colonization"></a><h2>Colonization</h2>

<p>With its <a href="/wiki/Flagella" id="w">flagella</a>, the bacterium moves through the stomach lumen and drills into the <a href="/wiki/Mucus" id="w">mucus</a> <a href="/wiki/Gel" id="w">gel</a> <a href="/wiki/Layer" id="w">layer</a> of the stomach.  It then finds ways to live in various areas of the stomach. The known areas include: inside the mucus gel layer (with a preference for the <a href="/wiki/Superficial" id="w">superficial</a> area), above <a href="/wiki/Epithelial" id="w">epithelial</a> <a href="/wiki/Cell_(biology)" id="w">cells</a>, and inside <a href="/wiki/Vacuole" id="w">vacuoles</a> formed by <i>H. pylori</i> in epithelial cells. It produces <a href="/wiki/Adhesin" id="w">adhesins</a> which bind to membrane-associated <a href="/wiki/Lipids" id="w">lipids</a> and <a href="/wiki/Carbohydrates" id="w">carbohydrates</a> and help its adhesion to epithelial cells. An example of this is the Lewis b antigen. It produces large amounts of <a href="/wiki/Urease" id="w">urease</a> <a href="/wiki/Enzyme" id="w">enzymes</a> which are localized inside and outside of the bacterium.  Urease metabolizes <a href="/wiki/Urea" id="w">urea</a> (which is normally  secreted into the stomach) to <a href="/wiki/Carbon_dioxide" id="w">carbon dioxide</a> and <a href="/wiki/Ammonia" id="w">ammonia</a> which neutralizes gastric acid. The survival of <i>H. pylori</i> in the acidic stomach is dependant on urease, and it would eventually die without it.  The ammonia that is produced is <a href="/wiki/Toxic" id="w">toxic</a> to the epithelial cells, and with other products of <i>H. pylori</i>, including <a href="/wiki/Protease" id="w">protease</a>, <a href="/wiki/Catalase" id="w">catalase</a>, and <a href="/wiki/Phospholipase" id="w">phospholipases</a>, causes <a href="/wiki/Damage" id="w">damage</a> to those cells. </p>
<p>Some <a href="/wiki/Strains" id="w">strains</a> of the bacteria have a particular mechanism for &#34;injecting&#34; the <a href="/wiki/Inflammation" id="w">inflammatory</a> inducing agents <a href="/wiki/Peptidoglycan" id="w">peptidoglycan</a> from their own <a href="/wiki/Cell_wall" id="w">cell wall</a> into epithelial stomach cells. (See below for &#34;cagA pathogenicity island&#34; in the section <a href="/wiki/Helicobacter_pylori#Genome studies of different strains" id="w">Genome studies of different strains</a>) This factor may play a role in allowing certain strains to invade <a href="/wiki/Host_(biology)" id="w">host</a> <a href="/wiki/Tissue" id="w">tissue</a>.<sup id="_ref-17" class="reference"><a href="#_note-17" title="">[17]</a></sup></p>
<a id="Causes_of_infection" name="Causes_of_infection"></a><h2> Causes of infection </h2>
<p>H. Pylori is bacterial/viral but it is believed to be transmitted orally so it might be contagious. Many researchers think that H. pylori is transmitted orally by means of fecal matter through the ingestion of waste tainted food or water. A clean and hygienic environment can help decrease the risk of H. Pylori infection.</p>
<a id="Diagnosis_of_infection" name="Diagnosis_of_infection"></a><h2>Diagnosis of infection</h2>
<p><div style="wigth:190px"><a class="internal" href="/wiki/Image:190px-Immunohistochemical_detection_of_Helicobacter_(1)_histopatholgy.jpg" title="[[Immunohistochemistry|Immunohistochemical]] staining of &#39;&#39;H. pylori&#39;&#39; from a [[stomach|gastric]] [[biopsy]]."><img src="http://en.wikipedia.org/wiki/190px-Immunohistochemical_detection_of_Helicobacter_(1)_histopatholgy.jpg" alt="[[Immunohistochemistry|Immunohistochemical]] staining of &#39;&#39;H. pylori&#39;&#39; from a [[stomach|gastric]] [[biopsy]]." title="[[Immunohistochemistry|Immunohistochemical]] staining of &#39;&#39;H. pylori&#39;&#39; from a [[stomach|gastric]] [[biopsy]]." class="location-none type-thumb" width="190px" />
</a>
<div class="thumbcaption"><a href="/wiki/Immunohistochemistry" id="w">Immunohistochemical</a> staining of <i>H. pylori</i> from a <a href="/wiki/Stomach" id="w">gastric</a> <a href="/wiki/Biopsy" id="w">biopsy</a>.</div></div>
</p>
<p>Diagnosis of infection is usually made by checking for <a href="/wiki/Dyspepsia" id="w">dyspeptic</a> symptoms and then doing tests which can suggest <i>H. pylori</i> infection.  One can test noninvasively for <i>H. pylori</i> infection with a <a href="/wiki/Blood" id="w">blood</a> <a href="/wiki/Antibody" id="w">antibody</a> test, stool <a href="/wiki/Antigen" id="w">antigen</a> <a href="/wiki/Stool_test" id="w">test</a>, or with the <a href="/wiki/Urea_breath_test" id="w">carbon urea breath test</a> (in which the patient drinks <a href="/wiki/Carbon-14" id="w">&#60;sup&#62;14&#60;/sup&#62;C</a>- or <a href="/wiki/Carbon-13" id="w">&#60;sup&#62;13&#60;/sup&#62;C</a>-labelled <a href="/wiki/Urea" id="w">urea</a>, which the bacterium metabolizes producing labelled <a href="/wiki/Carbon_dioxide" id="w">carbon dioxide</a> that can be detected in the breath).  However, the most reliable method for detecting <i>H. pylori</i> infection is a <a href="/wiki/Biopsy" id="w">biopsy</a> check during <a href="/wiki/Endoscopy" id="w">endoscopy</a> with a <a href="/wiki/Rapid_urease_test" id="w">rapid urease test</a>, <a href="/wiki/Histological" id="w">histological</a> examination, and microbial culture.  None of the test methods are completely failsafe. Even biopsy is dependent on the location of the biopsy. Blood antibody tests, for example, range from 76% to 84% <a href="/wiki/Sensitivity_(tests)" id="w">sensitivity</a>. Some drugs can affect <i>H. pylori</i> urease activity and give &#34;false negatives&#34; with the urea-based tests.</p>
<p>Infection may be symptomatic or asymptomatic (without perceptible ill effects).  It is estimated that up to 70% of infection is asymptomatic and that about 2/3 of the world population are infected by the bacterium, making it the most widespread infection in the world.  Actual infection rates vary from nation to nation - the West (Western Europe, North America, Australasia) having rates around 25% and much higher in the Third World. In the latter, it is common, probably due to poor sanitary conditions, to find infections in children. In the <a href="/wiki/United_States" id="w">United States</a>, infection is primarily in the older generations (about 50% for those over the age of 60 compared with 20% under 40 years) and the poorest.</p>
<p>This is largely attributed to higher hygiene standards and widespread use of antibiotics. However, <a href="/wiki/Antibiotic_resistance" id="w">antibiotic resistance</a> is appearing in <i>H. pylori</i>.<sup id="_ref-18" class="reference"><a href="#_note-18" title="">[18]</a></sup> There are already many <a href="/wiki/Metronidazole" id="w">metronidazole</a> resistant strains in <a href="/wiki/Europe" id="w">Europe</a>, the <a href="/wiki/United_States" id="w">United States</a>, and developing countries.</p>
<p>The bacteria have been isolated from <a href="/wiki/Feces" id="w">feces</a>, <a href="/wiki/Saliva" id="w">saliva</a> and <a href="/wiki/Dental_plaque" id="w">dental plaque</a> of infected patients, which suggests gastro-oral or fecal-oral as possible transmission routes.</p>
<p>It is widely believed that in the absence of treatment, <i>H. pylori</i> infection—once established in its gastric niche—persists for life.  In the elderly, however, it is likely infection can disappear as the stomach&#39;s mucosa becomes increasingly atrophic and inhospitable to colonization. The proportion of acute infections that persist is not known, but several studies that followed the natural history in populations have reported apparent spontaneous elimination.<sup id="_ref-Goodman_2005_a" class="reference"><a href="#_note-Goodman_2005" title="">[19]</a></sup><sup id="_ref-Goodman_2001_a" class="reference"><a href="#_note-Goodman_2001" title="">[20]</a></sup></p>
<a id="Treatment_of_infection" name="Treatment_of_infection"></a><h2>Treatment of infection</h2>
<p><a class="internal" href="/wiki/Image:pylorigastritis.jpg" title="&#39;&#39;H. pylori&#39;&#39; colonized on the surface of regenerative epithelium (image from Warthin-Starry&#39;s silver stain)"><img src="http://en.wikipedia.org/wiki/pylorigastritis.jpg" alt="&#39;&#39;H. pylori&#39;&#39; colonized on the surface of regenerative epithelium (image from Warthin-Starry&#39;s silver stain)" title="&#39;&#39;H. pylori&#39;&#39; colonized on the surface of regenerative epithelium (image from Warthin-Starry&#39;s silver stain)" class="location-none type-thumb" />
</a>
<div class="thumbcaption"><i>H. pylori</i> colonized on the surface of regenerative epithelium (image from Warthin-Starry&#39;s silver stain)</div>
In <a href="/wiki/Peptic_ulcer" id="w">peptic ulcer</a> patients where <a href="/wiki/Infection" id="w">infection</a> is detected, the normal procedure is eradicating <i>H. pylori</i> to allow the <a href="/wiki/Ulcer" id="w">ulcer</a> to heal. The standard first-line therapy is a one week <i>triple therapy</i>. The Sydney gastroenterolgist <a href="/wiki/Thomas_Borody" id="w">Thomas Borody</a> invented the first triple therapy in 1987.<sup id="_ref-Borody_1989_a" class="reference"><a href="#_note-Borody_1989" title="">[21]</a></sup> Today, the standard triple therapy is <a href="/wiki/Amoxicillin" id="w">amoxicillin</a>, <a href="/wiki/Clarithromycin" id="w">clarithromycin</a> and a <a href="/wiki/Proton_pump_inhibitor" id="w">proton pump inhibitor</a> such as <a href="/wiki/Omeprazole" id="w">omeprazole</a>.<sup id="_ref-Mirbagheri_et_al_2006_a" class="reference"><a href="#_note-Mirbagheri_et_al_2006" title="">[22]</a></sup> Variations of the triple therapy have been developed over the years, such as using a different <a href="/wiki/Proton_pump_inhibitor" id="w">proton pump inhibitor</a>, as with <a href="/wiki/Pantoprazole" id="w">pantoprazole</a> or <a href="/wiki/Rabeprazole" id="w">rabeprazole</a>, or using <a href="/wiki/Metronidazole" id="w">metronidazole</a> instead of amoxicillin in those <a href="/wiki/Allergy" id="w">allergic</a> to <a href="/wiki/Penicillin" id="w">penicillin</a>.<sup id="_ref-Maastricht_2_Consensus_Report_a" class="reference"><a href="#_note-Maastricht_2_Consensus_Report" title="">[23]</a></sup> Such a therapy has revolutionised the treatment of peptic ulcers and has made a cure to the <a href="/wiki/Disease" id="w">disease</a> possible, where previously symptom control using <a href="/wiki/Antacids" id="w">antacids</a>, <a href="/wiki/H2_antagonist" id="w">H&#60;sub&#62;2&#60;/sub&#62;-antagonists</a> or <a href="/wiki/Proton_pump_inhibitor" id="w">proton pump inhibitors</a> alone was the only option.<sup id="_ref-pmid1971318_a" class="reference"><a href="#_note-pmid1971318" title="">[24]</a></sup><sup id="_ref-pmid1854110_a" class="reference"><a href="#_note-pmid1854110" title="">[25]</a></sup></p>
<p>A <a href="/wiki/Meta-analysis" id="w">meta-analysis</a> of <a href="/wiki/Randomized_controlled_trials" id="w">randomized controlled trials</a> suggests that supplementation with <a href="/wiki/Probiotics" id="w">probiotics</a> can improve eradication rates and reduce adverse events.<sup id="_ref-pmid17229240_a" class="reference"><a href="#_note-pmid17229240" title="">[26]</a></sup></p>
<p>Unfortunately, an increasing number of infected individuals are found to harbour <a href="/wiki/Antibiotic_resistance" id="w">antibiotic-resistant</a> bacteria. This results in initial treatment failure and requires additional rounds of antibiotic therapy or alternative strategies such as a quadruple therapy.   <a href="/wiki/Bismuth" id="w">Bismuth</a> compounds are also effective in combination with the above drugs. For the treatment of <a href="/wiki/Clarithromycin" id="w">clarithromycin</a>-resistant strains of <i>H. pylori</i> the use of <a href="/wiki/Levofloxacin" id="w">levofloxacin</a> as part of the therapy has been suggested.</p>
<p>Some studies show that consumption of <a href="/wiki/Broccoli" id="w">broccoli</a> sprouts can be effective at inhibiting <i>H. pylori</i> growth<sup id="_ref-27" class="reference"><a href="#_note-27" title="">[27]</a></sup> with <a href="/wiki/Sulforaphane" id="w">sulforaphane</a> being at least one of the active agents<sup id="_ref-28" class="reference"><a href="#_note-28" title="">[28]</a></sup>.</p>
<p>Some studies show that <a href="/wiki/Mastic" id="w">mastic</a> gum can destroy <i>H. pylori</i> <i><a href="/wiki/In_vitro" id="w">in vitro</a></i>, but studies done <i><a href="/wiki/In_vivo" id="w">in vivo</a></i> have shown it to be ineffective.<sup id="_ref-29" class="reference"><a href="#_note-29" title="">[29]</a></sup></p>
<p>A study done on Mongolian gerbils indicates that <a href="/wiki/Green_tea" id="w">green tea</a> extract can suppress <i>H. pylori</i> growth.<sup id="_ref-30" class="reference"><a href="#_note-30" title="">[30]</a></sup> Another study done in South Korea suggests that an acidic <a href="/wiki/Polysaccharide" id="w">polysaccharide</a> found in green tea is significantly effective in preventing adhesion of <i>H. pylori</i> to human cultures of epithelial cells.<sup id="_ref-Lee_2006_a" class="reference"><a href="#_note-Lee_2006" title="">[31]</a></sup></p>
<p>As <a href="/wiki/#Acid reflux and esophageal cancer" id="w">explained below</a>, some authors suggest that some strains of <i>H. pylori</i> may be protective against certain diseases of the esophagus and cardia. Therefore, a more cautious approach than complete eradication may be necessary in some cases.</p>
<a id="''Helicobacter''_and_cancer" name="''Helicobacter''_and_cancer"></a><h2>&#39;&#39;Helicobacter&#39;&#39; and cancer</h2>

<p>While the <a href="/wiki/Incidence_(epidemiology)" id="w">incidence</a> of <i>H. pylori</i> infection in humans is decreasing in developing countries,{{Fact}} presumably because of improving sanitation and increasing use of antibiotics, in the United States the incidence of gastric cancer has decreased by 80 percent from 1900 to 2000.  This apparent correlation is consistent with an epidemiological link between <i>H. pylori</i> and cancer.  Specifically, both <a href="/wiki/Gastric_cancer" id="w">gastric cancer</a> and gastric <a href="/wiki/MALT_lymphoma" id="w">MALT lymphoma</a> (lymphoma of the <a href="/wiki/Mucosa-associated_lymphoid_tissue" id="w">mucosa-associated lymphoid tissue</a>) have been associated with <i>H. pylori</i>, and the bacterium has been categorized as a group I <a href="/wiki/Carcinogen" id="w">carcinogen</a> by the <a href="/wiki/International_Agency_for_Research_on_Cancer" id="w">International Agency for Research on Cancer</a> (IARC).  Despite these associations, a direct <a href="/wiki/Causality" id="w">causal</a> relationship has not been demonstrated.  Nonetheless, among <a href="/wiki/Cancer_bacteria" id="w">bacteria suspected to cause cancer</a>, <i>H. pylori</i> is the leading contender.</p>
<p>Two related mechanisms by which <i>H. pylori</i> could promote <a href="/wiki/Cancer" id="w">cancer</a> are under investigation. One mechanism involves the enhanced production of <a href="/wiki/Free_radical" id="w">free radicals</a> near <i>H. pylori</i> and an increased rate of host cell <a href="/wiki/Mutation" id="w">mutation</a>. The other proposed mechanism has been called a &#34;perigenetic pathway&#34;<sup id="_ref-32" class="reference"><a href="#_note-32" title="">[32]</a></sup> and involves enhancement of the transformed host cell phenotype by means of alterations in cell <a href="/wiki/Protein" id="w">proteins</a> such as <a href="/wiki/Cell_adhesion" id="w">adhesion</a> proteins. It has been proposed that <i>H. pylori</i> induces <a href="/wiki/Inflammation" id="w">inflammation</a> and locally high levels of <a href="/wiki/TNF-alpha" id="w">TNF-alpha</a> and/or <a href="/wiki/Interleukin_6" id="w">interleukin 6</a>. According to the proposed perigenetic mechanism, inflammation-associated signaling molecules such as TNF-alpha can alter gastric epithelial cell adhesion and lead to the dispersion and migration of mutated epithelial cells without the need for additional mutations in <a href="/wiki/Tumor_suppressor_gene" id="w">tumor suppressor genes</a> such as <a href="/wiki/Genes" id="w">genes</a> that code for cell adhesion proteins.</p>
<a id="Acid_reflux_and_esophageal_cancer" name="Acid_reflux_and_esophageal_cancer"></a><h3>Acid reflux and esophageal cancer</h3>
<p>As the incidence of gastric cancer has decreased, the incidences of <a href="/wiki/Gastroesophageal_reflux_disease" id="w">gastroesophageal reflux disease</a> and <a href="/wiki/Esophageal_cancer" id="w">esophageal cancer</a> have increased dramatically. In 1996, <a href="/wiki/Martin_J._Blaser" id="w">Martin J. Blaser</a> put forward the theory that <i>H. pylori</i> might also have a beneficial effect: by regulating the acidity of the stomach contents, it lowers the impact of regurgitation of gastric acid into the esophagus.<sup id="_ref-Blaser_2005_b" class="reference"><a href="#_note-Blaser_2005" title="">[2]</a></sup> While some favorable evidence has been accumulated, <a href="/wiki/As_of_2005" id="w">as of 2005</a> the theory is not universally accepted.</p>
<a id="Genome_studies_of_different_strains" name="Genome_studies_of_different_strains"></a><h2>Genome studies of different strains</h2>
<p><a class="internal" href="/wiki/Image:Helicobacter_pylori.jpg" title="EM photograph of &#39;&#39;H. pylori&#39;&#39;"><img src="http://en.wikipedia.org/wiki/Helicobacter_pylori.jpg" alt="EM photograph of &#39;&#39;H. pylori&#39;&#39;" title="EM photograph of &#39;&#39;H. pylori&#39;&#39;" class="location-none type-thumb" />
</a>
<div class="thumbcaption">EM photograph of <i>H. pylori</i></div>
Several strains are known, and the <a href="/wiki/Genome" id="w">genomes</a> of two have been completely <a href="/wiki/Sequencing" id="w">sequenced</a>.<sup id="_ref-33" class="reference"><a href="#_note-33" title="">[33]</a></sup> The genome of the strain &#34;26695&#34; consists of about 1.7 million <a href="/wiki/Base_pair" id="w">base pairs</a>, with some 1550 genes. The two sequenced strains show large genetic differences, with up to 6% of the <a href="/wiki/Nucleosides" id="w">nucleosides</a> differing.</p>
<p>Study of the <i>H. pylori</i> genome is centered on attempts to understand <a href="/wiki/Pathogenesis" id="w">pathogenesis</a>, the ability of this <a href="/wiki/Organism" id="w">organism</a> to cause disease. There are 62 genes in the &#34;pathogenesis&#34; category of the genome database. Both sequenced strains have an approximately 40 kb long Cag <a href="/wiki/Pathogenicity_island" id="w">pathogenicity island</a> (a common gene sequence believed responsible for pathogenesis) that contains over 40 genes. This pathogenicity island is usually absent from <i>H. pylori</i> strains isolated from humans who are carriers of <i>H. pylori</i> but remain <a href="/wiki/Asymptomatic" id="w">asymptomatic</a>. </p>
<p>The cagA gene codes for one of the major <i>H. pylori</i> <a href="/wiki/Virulence" id="w">virulence</a> proteins. Bacterial strains that have the cagA gene are associated with an ability to cause severe ulcers. The cagA gene codes for a relatively long (1186 <a href="/wiki/Amino_acid" id="w">amino acid</a>) protein. The cagA protein is transported into human cells where it may disrupt the normal functioning of the <a href="/wiki/Cytoskeleton" id="w">cytoskeleton</a>. The Cag pathogenicity island has about 30 genes that code for a complex <a href="/wiki/Type_IV_secretion_system" id="w">type IV secretion system</a>. After attachment of <i>H.pylori</i> to stomach epithelial cells, the cagA protein is injected into the epithelial cells by the type IV secretion system. The cagA protein is <a href="/wiki/Phosphorylation" id="w">phosphorylated</a> on <a href="/wiki/Protein_kinase#Tyrosine-specific protein kinases" id="w">tyrosine residues</a> by a host cell membrane-associated <a href="/wiki/Tyrosine_kinase" id="w">tyrosine kinase</a>. Pathogenic strains of <i>H. pylori</i> have been shown to activate the <a href="/wiki/Epidermal_growth_factor_receptor" id="w">epidermal growth factor receptor</a> (EGFR), a membrane protein with a tyrosine kinase domain. Activation of the EGFR by <i>H. pylori</i> is associated with altered <a href="/wiki/Signal_transduction" id="w">signal transduction</a> and <a href="/wiki/Gene_expression" id="w">gene expression</a> in host epithelial cells that may contribute to pathogenesis. It has also been suggested that a <a href="/wiki/C-terminus" id="w">c-terminal</a> region of the cagA protein (amino acids 873–1002) can regulate host cell gene transcription independent of protein tyrosine phosphorylation.  It is thought, due to cagA&#39;s low GC content relative to the rest of the helicobacter genome, that the gene was acquired by horizontal transfer from another cagA+ bacterial species.</p>
<p>Each human population has a characteristic distribution of <i>H. pylori</i> strains that typically infect members of that population. This allows researchers to use <i>H. pylori</i> to study human migration patterns. It could be established that <i>H. pylori</i> in <a href="/wiki/Indigenous_people_of_Brazil" id="w">Amazon Indians</a> has East Asian rather than European origins, suggesting that it arrived with the original immigrants at least 11,000 years ago.{{Fact}}</p>
<a id="See_also" name="See_also"></a><h2>See also</h2>

<ul>
<li><a href="/wiki/Gastritis" id="w">Gastritis</a></li>
<li><a href="/wiki/Peptic_ulcer" id="w">Peptic ulcer</a></li>
<li><a href="/wiki/Stomach" id="w">Stomach</a></li></ul>
<a id="Notes" name="Notes"></a><h2>Notes</h2>
<p>{{Reflist}}</p>
<a id="References" name="References"></a><h2>References</h2>

<ul>
<li>{{cite web}}</li>
<li>{{cite journal}}</li></ul>
<a id="External_links" name="External_links"></a><h2>External links</h2>
<p>{{wikispecies}}
{{Commonscat}}
</p>
<ul>
<li><a class="externallink" href="http://www.helico.com/" rel="nofollow" title="http://www.helico.com/">The Helicobacter Foundation</a> provides information on <i>Helicobacter pylori</i> and its effects - founded by Dr. Barry J. Marshall, one of the discoverers of <i>H. pylori</i></li>
<li><a class="externallink" href="http://www.pubmedcentral.gov/articlerender.fcgi?tool=pubmed&#38;pubmedid=14755326" rel="nofollow" title="http://www.pubmedcentral.gov/articlerender.fcgi?tool=pubmed&#38;pubmedid=14755326">&#39;&#39;Helicobacter pylori&#39;&#39; persistence: biology and disease</a> by Martin J. Blaser and John C. Atherton in <i>Journal of Clinical Investigations (2004) Volume 113 pages 321–333.</i></li>
<li><a class="externallink" href="http://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=hp" rel="nofollow" title="http://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=hp">&#39;&#39;Helicobacter pylori&#39;&#39;: Physiology and Genetics</a> Online text of the Mobley et al book (via NCBI).</li>
<li><a class="externallink" href="http://www.helicobacter.org/" rel="nofollow" title="http://www.helicobacter.org/">European Helicobacter Study Group</a> sponsors annual international workshop, yearbook, and clinical guidelines
<ul>
<li><a class="externallink" href="http://www.helicobacter.org/content/publications/helicobacter_2006/yih2006.pdf" rel="nofollow" title="http://www.helicobacter.org/content/publications/helicobacter_2006/yih2006.pdf">The Year in &#39;&#39;Helicobacter pylori&#39;&#39; 2006</a> Helicobacter journal Supplement Oct 2006 - Free content </li>
<li><a class="externallink" href="http://www.helicobacter.org/content/publications/publications.htm" rel="nofollow" title="http://www.helicobacter.org/content/publications/publications.htm">1994–2005 back issues</a></li></ul></li>
<li>Atwood KC. <i>Bacteria, Ulcers, and Ostracism?: H. pylori and the Making of a Myth.</i> Skeptical Inquirer November 2004. <a class="externallink" href="http://www.csicop.org/si/2004-11/bacteria.html" rel="nofollow" title="http://www.csicop.org/si/2004-11/bacteria.html">Fulltext</a> Claims that medicine’s purported ostracism of the discovery of <i>H. pylori</i> has achieved a mythological quality, but isn&#39;t true: after appropriate initial scientific skepticism, the hypothesis was accepted right &#34;on schedule&#34;.</li>
<li><a class="externallink" href="http://www.pathologyatlas.ro/Helicobacter%20pylori.html" rel="nofollow" title="http://www.pathologyatlas.ro/Helicobacter%20pylori.html">Microscopic image of &#39;&#39;H. pylori&#39;&#39;</a></li>
<li><a class="externallink" href="http://www.hpylori.com.au/picturebook.html" rel="nofollow" title="http://www.hpylori.com.au/picturebook.html">&#39;&#39;H. pylori&#39;&#39; Picture Book</a></li>
<li><a class="externallink" href="http://www.dsmz.de/bactnom/nam3637.htm" rel="nofollow" title="http://www.dsmz.de/bactnom/nam3637.htm">List of species in the genus &#39;&#39;Helicobacter&#39;&#39;</a></li>
<li><a class="externallink" href="http://www.sciencedaily.com/releases/2007/02/070215134529.htm" rel="nofollow" title="http://www.sciencedaily.com/releases/2007/02/070215134529.htm">&#39;&#39;Out Of Africa -- Bacteria, As Well:&#39;&#39; Homo Sapiens &#39;&#39;And&#39;&#39; H. Pylori &#39;&#39;Jointly Spread Across The Globe&#39;&#39;</a> ScienceDaily (Feb. 16, 2007) — When man made his way out of Africa some 60,000 years ago to populate the world, he was not alone: He was accompanied by the bacterium <i>Helicobacter pylori</i>....</li></ul>
<p>{{featured article}}</p>
<p>


</p>
<p>{{link FA}}
{{Link FA}}
{{Link FA}}
<a href="http://zh-min-nan.wikipedia.org/wiki/Helicobacter_pylori">zh-min-nan:Helicobacter pylori</a>
<a href="http://be-x-old.wikipedia.org/wiki/Helicobacter_pylori">be-x-old:Helicobacter pylori</a>
<a href="http://bg.wikipedia.org/wiki/Helicobacter_pylori">bg:Helicobacter pylori</a>
<a href="http://ca.wikipedia.org/wiki/Helicobacter_pylori">ca:Helicobacter pylori</a>
<a href="http://da.wikipedia.org/wiki/Helicobacter_pylori">da:Helicobacter pylori</a>
<a href="http://de.wikipedia.org/wiki/Helicobacter_pylori">de:Helicobacter pylori</a>
<a href="http://es.wikipedia.org/wiki/Helicobacter_pylori">es:Helicobacter pylori</a>
<a href="http://fr.wikipedia.org/wiki/Helicobacter_pylori">fr:Helicobacter pylori</a>
<a href="http://ko.wikipedia.org/wiki/헬%EB%A6%AC%EC%BD%94%EB%B0%95%ED%84%B0_%ED%8C%8C%EC%9D%BC%EB%A1%9C%EB%A6%AC">ko:헬리코박터 파일로리</a>
<a href="http://it.wikipedia.org/wiki/Helicobacter_pylori">it:Helicobacter pylori</a>
<a href="http://he.wikipedia.org/wiki/Helicobacter_pylori">he:Helicobacter pylori</a>
<a href="http://la.wikipedia.org/wiki/Helicobacter_Pylori">la:Helicobacter Pylori</a>
<a href="http://lb.wikipedia.org/wiki/Helicobacter_pylori">lb:Helicobacter pylori</a>
<a href="http://nl.wikipedia.org/wiki/Helicobacter_pylori">nl:Helicobacter pylori</a>
<a href="/wiki/New:%E0%A4%B9%E0%A5%87%E0%A4%B2%E0%A4%BF%E0%A4%95%E0%A5%8B%E0%A4%AC%E0%A5%8D%E0%A4%AF%E0%A4%BE%E0%A4%95%E0%A5%8D%E0%A4%9F%E0%A4%B0_%E0%A4%AA%E0%A4%BE%E0%A4%87%E0%A4%B2%E0%A5%8B%E0%A4%B0%E0%A5%80" id="w">new:हेलिकोब्याक्टर पाइलोरी</a>
<a href="http://ja.wikipedia.org/wiki/ヘ%E3%83%AA%E3%82%B3%E3%83%90%E3%82%AF%E3%82%BF%E3%83%BC%E3%83%BB%E3%83%94%E3%83%AD%E3%83%AA">ja:ヘリコバクター・ピロリ</a>
<a href="http://no.wikipedia.org/wiki/Helicobacter_pylori">no:Helicobacter pylori</a>
<a href="http://nn.wikipedia.org/wiki/Helicobacter_pylori">nn:Helicobacter pylori</a>
<a href="http://pl.wikipedia.org/wiki/Helicobacter_pylori">pl:Helicobacter pylori</a>
<a href="http://pt.wikipedia.org/wiki/Helicobacter_pylori">pt:Helicobacter pylori</a>
<a href="http://ro.wikipedia.org/wiki/Helicobacter_Pylori">ro:Helicobacter Pylori</a>
<a href="http://ru.wikipedia.org/wiki/Helicobacter_pylori">ru:Helicobacter pylori</a>
<a href="http://sk.wikipedia.org/wiki/Helicobacter_pylori">sk:Helicobacter pylori</a>
<a href="http://fi.wikipedia.org/wiki/Helicobacter_pylori">fi:Helicobacter pylori</a>
<a href="http://sv.wikipedia.org/wiki/Helicobacter_pylori">sv:Helicobacter pylori</a>
<a href="http://tr.wikipedia.org/wiki/Helicobacter_pylori">tr:Helicobacter pylori</a>
<a href="http://uk.wikipedia.org/wiki/Helicobacter_pylori">uk:Helicobacter pylori</a>
<a href="http://zh.wikipedia.org/wiki/幽%E9%96%80%E8%9E%BA%E6%A1%BF%E8%8F%8C">zh:幽門螺桿菌</a>
</p>